Back to 
JACOBS LEVY EQUITY MANAGEMENT, INC
JACOBS LEVY EQUITY MANAGEMENT, INC
CUE
Showing 0 of 2 quarters
Position history for JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in CUE BIOPHARMA INC
No. Jacobs Levy Equity Management exited its CUE (Cue Biopharma) position in Q1 2023. Its Q4 2022 13F listed 69,522 shares worth $198,138. Jacobs Levy Equity Management first reported CUE in Q4 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.